相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease
Qing-Song Lin et al.
LABORATORY INVESTIGATION (2020)
Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibition
Hugo Brito et al.
CELL DEATH DISCOVERY (2020)
Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease
Pedro A. Dionisio et al.
CELL DEATH & DISEASE (2019)
Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease Models
Angelo Iannielli et al.
CELL REPORTS (2018)
Phenotypic screening identifies a new oxazolone inhibitor of necroptosis and neuroinflammation
Sara R. Oliveira et al.
CELL DEATH DISCOVERY (2018)
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
Philip A. Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Necroptosis activation in Alzheimer's disease
Antonella Caccamo et al.
NATURE NEUROSCIENCE (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Initiation and execution mechanisms of necroptosis: an overview
Sasker Grootjans et al.
CELL DEATH AND DIFFERENTIATION (2017)
Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Regulated necrosis: disease relevance and therapeutic opportunities
Marcus Conrad et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+
Stefan Schildknecht et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Activation of Necroptosis in Multiple Sclerosis
Dimitry Ofengeim et al.
CELL REPORTS (2015)
Regulation of tumour necrosis factor signalling: live or let die
Dirk Brenner et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Characterization of GSK'963: a structurally distinct, potent and selective inhibitor of RIP1 kinase
S. B. Berger et al.
CELL DEATH DISCOVERY (2015)
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
Pratyusha Mandal et al.
MOLECULAR CELL (2014)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models
P. Vandenabeele et al.
CELL DEATH AND DIFFERENTIATION (2013)
Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase
A. Degterev et al.
CELL DEATH AND DIFFERENTIATION (2013)
Unsaturated oxazolones as nonlinear fluorophores
Catarina A. B. Rodrigues et al.
DYES AND PIGMENTS (2013)
Structural Basis of RIP1 Inhibition by Necrostatins
Tian Xie et al.
STRUCTURE (2013)
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis
Philip A. Harris et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
A novel role for RIP1 kinase in mediating TNFα production
D. E. Christofferson et al.
CELL DEATH & DISEASE (2012)
Programmed Cell Death in Parkinson's Disease
Katerina Venderova et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
zVAD-induced necroptosis in L929 cells depends on autocrine production of TNF alpha mediated by the PKC-MAPKs-AP-1 pathway
Y-T Wu et al.
CELL DEATH AND DIFFERENTIATION (2011)
The Adaptor Protein FADD Protects Epidermal Keratinocytes from Necroptosis In Vivo and Prevents Skin Inflammation
Marion C. Bonnet et al.
IMMUNITY (2011)
MPTP Mouse Models of Parkinson's Disease: An Update
Gloria E. Meredith et al.
JOURNAL OF PARKINSONS DISEASE (2011)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps
Oren A. Levy et al.
APOPTOSIS (2009)
RIP Kinases at the Crossroads of Cell Death and Survival
Wim Declercq et al.
CELL (2009)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
GSTpi Expression in MPTP-Induced Dopaminergic Neurodegeneration of C57BL/6 Mouse Midbrain and Striatum
Margarida Castro-Caldas et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2009)
TNF-α induces two distinct caspase-8 activation pathways
Lai Wang et al.
CELL (2008)
High throughput microsomal stability assay for insoluble compounds
Li Di et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Structure-activity relationship study of novel necroptosis inhibitors
X Teng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
A Degterev et al.
NATURE CHEMICAL BIOLOGY (2005)
Attenuation of staurosporine-induced apoptosis, oxidative stress, and mitochondrial dysfunction by synthetic superoxide dismutase and catalase mimetics, in cultured cortical neurons
K Pong et al.
EXPERIMENTAL NEUROLOGY (2001)
MPTP activates c-Jun NH2-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo
MS Saporito et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
